Part of Phaidon International
Part of Phaidon International
Showing 66 results
Sort by:
About the OpportunityAn innovative clinical-stage biotechnology company is seeking an experienced Clinical Trial Manager to support the delivery of next-generation therapies and vaccines. This is an opportunity to join a highly collaborative, science-driven environment focused on advancing novel treatment approaches and improving patient outcomes w...
About the OpportunityA growing specialist Contract Research Organisation (CRO) is seeking an experienced Clinical Project Manager to join its expanding team in Germany. With approximately 50 employees, this organization offers a highly collaborative environment where project managers have strong visibility, autonomy, and direct impact on study deli...
An innovative and rapidly growing international CRO is seeking an experienced Clinical Project Manager to join its Clinical Operations team. This is a rare opportunity to become the organisation's first Clinical Project Manager in Germany and play a pivotal role in supporting ongoing growth across Europe.With operations spanning multiple regions an...
Take the first step toward your next opportunity - submit your CV and get started today.
R&D Project Manager (Oncology)Location: GermanySector: Innovative Biopharmaceutical CompanyStatus: Confidential SearchA highly innovative biopharmaceutical company is seeking an experienced R&D Project Manager to support the progression of a growing oncology portfolio.This is a highly visible role at the intersection of science, development, and st...
EPM Scientific are working with a leading firm who are seeking a Executive Director to join their team. Reporting into the SVP of Biometrics, this is the senior-most Clinical Data Management leader within the organization. You'll own the CDM strategy, lead and develop the team, and serve as a key partner to executive leadership as the company adva...
The OpportunityThis is a rare chance to step in as the in‑region clinical operations lead for APAC at a privately backed, clinical‑stage biotech entering a decisive phase of growth. The company has moved beyond platform promise into execution - multiple programs advancing, real patients enrolling, and global timelines that now depend on strong regi...